Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03023215 · ClinicalTrials.gov registry record · NA
Brief Guided Relaxation for Women Undergoing Stereotactic Breast Biopsy
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT03023215: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT03023215 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03023215, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
The goal of this behavioral research study is to learn if taking part in guided relaxation programs helps to reduce anxiety and pain during stereotactic breast biopsy. The study will also examine whether the guided relaxation programs change brain activity, heart rate, and blood pressure.
Interventions
- BEHAVIORAL Questionnaires
- PROCEDURE Electroencephalogram
- PROCEDURE Meditation
- PROCEDURE Heart Rate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2012-10-26 |
| Est. Completion | 2022-08-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03023215
The ClinicalTrials.gov registry entry for NCT03023215 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Questionnaires is the first listed.
NCT03023215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03023215 about?
NCT03023215 is a clinical study titled "Brief Guided Relaxation for Women Undergoing Stereotactic Breast Biopsy". The goal of this behavioral research study is to learn if taking part in guided relaxation programs helps to reduce anxiety and pain during stereotactic breast biopsy. The study will also examine whether the guided relaxation programs change brain activity, heart rate, and blood pressure.
What is the current status of trial NCT03023215?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2012-10-26. Estimated completion is 2022-08-10.
What interventions are being tested in trial NCT03023215?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Electroencephalogram (PROCEDURE), Meditation (PROCEDURE), Heart Rate (PROCEDURE).
Who is sponsoring clinical trial NCT03023215?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.